6533b7d4fe1ef96bd1262a3c

RESEARCH PRODUCT

Development and Validation of Hepamet Fibrosis Scoring System-A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis.

Salvador BenllochJavier CrespoMing-hua ZhengManuel Romero‐gomezJudith Gómez-camareroJuan TurnesJesus M. BanalesMiguel Fernández-bermejoRubén FrancésVlad RatziuPatricia AspichuetaJavier García-samaniegoCarmelo García-monzónRocío Gallego-duránAurora GiannettiJavier SalmerónConrado M. Fernández-rodríguezJérôme BoursierDesamparados EscuderoMoisés DiagoJoan CaballeríaEduardo VilarAgustín AlbillosRaluca PaisGermán SorianoJose Luis CallejaElvira Del Pozo MarotoJavier AmpueroJosé Miguel RosalesM.t.a. LosteRocío AllerFrancisco JorqueraRaúl J. AndradeSalvatore PettaOreste Lo IaconoSalvador AgustinRebeca SigüenzaPamela Estévez

subject

AdultLiver CirrhosisMalemedicine.medical_specialtySteatosis[SDV]Life Sciences [q-bio]BiopsyLikelihood ratios in diagnostic testingGastroenterologySeverity of Illness IndexDecision Support Techniques03 medical and health sciences0302 clinical medicineFibrosisNon-alcoholic Fatty Liver DiseasePositive predicative valueInternal medicineNonalcoholic fatty liver diseaseHOMAMedicineHumansComputingMilieux_MISCELLANEOUSAged2. Zero hungerNASH FIBROSISHepatologymedicine.diagnostic_testReceiver operating characteristicbusiness.industryPrognostic FactorGastroenterologyOdds ratioMiddle Agedmedicine.diseasePrognosis3. Good healthCross-Sectional StudiesDiagnostic ToolCirrhosisLiver030220 oncology & carcinogenesisLiver biopsyDiagnostic odds ratio030211 gastroenterology & hepatologyFemalebusiness

description

HEPAmet Registry.

10.1016/j.cgh.2019.05.051https://pubmed.ncbi.nlm.nih.gov/31195161